Loading...
Systemic Treatment Options in Hepatocellular Carcinoma
BACKGROUND: Patients with advanced hepatocellular carcinoma (HCC) typically have poor survival outcomes. Until recently, sorafenib was the only systemic therapy option available and no agents were approved after sorafenib failure. However, rapid changes are beginning to emerge in the treatment lands...
Saved in:
| Published in: | Liver Cancer |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
S. Karger AG
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6883446/ https://ncbi.nlm.nih.gov/pubmed/31799201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000499765 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|